IRIS
CARAMORI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.096
NA - Nord America 7.704
AS - Asia 7.467
SA - Sud America 3.652
AF - Africa 218
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.153
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.513
RU - Federazione Russa 5.433
BR - Brasile 3.102
SG - Singapore 2.883
CN - Cina 2.232
IE - Irlanda 1.417
HK - Hong Kong 865
VN - Vietnam 678
IT - Italia 617
SE - Svezia 589
FR - Francia 377
AR - Argentina 208
DE - Germania 177
IN - India 136
PL - Polonia 110
EC - Ecuador 98
BD - Bangladesh 96
GB - Regno Unito 84
TR - Turchia 80
MX - Messico 78
CO - Colombia 77
ID - Indonesia 73
FI - Finlandia 62
ZA - Sudafrica 62
IQ - Iraq 60
CA - Canada 49
VE - Venezuela 48
UA - Ucraina 47
PY - Paraguay 42
PK - Pakistan 41
UZ - Uzbekistan 39
MA - Marocco 37
JP - Giappone 31
CL - Cile 29
AT - Austria 26
BE - Belgio 26
NL - Olanda 26
TN - Tunisia 23
KE - Kenya 21
PE - Perù 21
AZ - Azerbaigian 20
JO - Giordania 20
KZ - Kazakistan 19
NP - Nepal 17
AE - Emirati Arabi Uniti 16
EG - Egitto 16
UY - Uruguay 16
IL - Israele 14
ES - Italia 13
PA - Panama 13
SA - Arabia Saudita 13
AL - Albania 12
DO - Repubblica Dominicana 12
OM - Oman 12
PH - Filippine 12
BG - Bulgaria 11
BO - Bolivia 11
CZ - Repubblica Ceca 11
TH - Thailandia 11
MY - Malesia 10
SN - Senegal 10
AU - Australia 9
CH - Svizzera 9
DZ - Algeria 9
GE - Georgia 9
HN - Honduras 9
KR - Corea 9
LK - Sri Lanka 9
LT - Lituania 9
TW - Taiwan 9
CI - Costa d'Avorio 8
GR - Grecia 8
JM - Giamaica 8
KG - Kirghizistan 8
BH - Bahrain 7
ET - Etiopia 7
AM - Armenia 6
AO - Angola 6
CR - Costa Rica 6
IR - Iran 6
PS - Palestinian Territory 5
RS - Serbia 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
GT - Guatemala 4
LB - Libano 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CG - Congo 3
EE - Estonia 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
BW - Botswana 2
GA - Gabon 2
HR - Croazia 2
KH - Cambogia 2
Totale 28.122
Salva come PNG Salva come JPEG
Città #
Moscow 2.027
Dublin 1.417
Ashburn 1.342
Singapore 1.157
Hong Kong 861
Dallas 797
Beijing 671
Chandler 537
Dearborn 509
The Dalles 440
Nyköping 397
Princeton 326
Lauterbourg 277
Jacksonville 269
San Jose 268
Ho Chi Minh City 261
São Paulo 252
Des Moines 232
San Mateo 224
Cambridge 219
Messina 199
Los Angeles 187
Medford 167
Hanoi 139
Redondo Beach 128
Jinan 116
Tianjin 113
Shenyang 110
Warsaw 106
Buffalo 105
Rio de Janeiro 94
Belo Horizonte 76
Guangzhou 66
Nanjing 64
Curitiba 61
Munich 61
Wilmington 59
Ningbo 58
Zhengzhou 56
New York 51
Orem 50
Ann Arbor 48
Hebei 47
Brasília 45
Bremen 45
Haikou 39
Porto Alegre 39
Campinas 38
Lanzhou 38
Nanchang 38
Naples 38
Tashkent 38
Pune 37
Rome 37
Salvador 35
Haiphong 34
Shanghai 34
Turku 34
Hangzhou 33
Quito 32
Guarulhos 28
Taizhou 28
Santa Clara 27
Tokyo 27
Baghdad 26
Ribeirão Preto 26
Chennai 25
Bogotá 24
Brussels 24
Guayaquil 24
Santo André 24
Brooklyn 23
Da Nang 23
Jakarta 23
Asunción 22
Fortaleza 22
Milan 22
Shenzhen 22
Frankfurt am Main 21
Council Bluffs 20
Fuzhou 20
Goiânia 20
Istanbul 20
Johannesburg 20
Thái Bình 20
Caxias do Sul 19
Changsha 19
Denver 19
London 19
Maceió 19
Nairobi 19
Baku 18
Cape Town 18
Recife 18
Sorocaba 18
Betim 17
Buenos Aires 17
Jiaxing 17
Nuremberg 17
Dhaka 16
Totale 16.129
Salva come PNG Salva come JPEG
Nome #
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 256
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 230
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 224
An unusual cause of chest pain 206
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 193
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 186
A case of fibrosing interstitial pneumonia 183
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 183
Molecular links between COPD and lung cancer: new targets for drug discovery? 182
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 174
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 172
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 171
Autoimmunity and COPD: Clinical Implications 170
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 162
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 160
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 160
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 155
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 154
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance 150
Bacterial infections in the lungs of patients with systemic autoimmune diseases 150
Role of the mucins in pathogenesis of COPD: implications for therapy 149
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 149
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 149
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 146
Polmonite interstiziale fibrosante da amiodarone 145
Immunomodulatory effect of gefitinib in epidermal growth factor receptor tyrosine kinase inhibitors sensitive and resistant Non small cell lung cancer: role of the RNA binding protein HuR 143
2 agonisti inalatori nel trattamento dell’asma bronchiale e delle broncopneumopatie croniche ostruttive. 138
Anatomia e fisiologia clinica della pleura. 138
Allergen Responses Modified by a GATA3 DNAzyme 136
Posttranscriptional Gene Regulatory Networks in Chronic Airway Inflammatory Diseases: In silico Mapping of RNA-Binding Protein Expression in Airway Epithelium 136
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 134
Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease 133
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 133
Trattamento personalizzato dei pazienti con BPCO in fase stabile [Personalised treatment of stable COPD patients] 131
Commentary on "Major Complications Associated with Conventional Transbronchial Needle Aspiration" 131
A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. 128
New drugs under development for COPD 128
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 126
Transcription inhibitors and inflammatory cell activity 125
Gender differences in COPD management in a Sicilian general practice setting: a cohort study evaluating the impact of educational interventions 125
Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. 123
Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD 121
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 119
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 117
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 115
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. 114
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 114
IL-33 immunohistochemical pattern of expression in neoplastic and nonneoplastic peripheral lung tissues of stage 1 o 2 lung adenocarcinoma 114
Activation of NF-kappaB transcription factor in asthma death 113
Airway obstruction in chronic obstructive pulmonary disease. 113
Functional role of inflammasome activation in a subset of obese nonsmoking patients with severe asthma 112
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 109
TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase 108
Treatable traits in COPD patients 108
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 108
Asthma under/misdiagnosis in primary care setting: An observational community-based study in Italy 107
A link between lung injury and inflammatory myopathies: making the diagnosis 106
OXIDANTS AND ANTIOXIDANTS | Antioxidants, Nonenzymatic 106
Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation 103
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 103
Epithelial Posttranscriptional Gene Regulatory Networks In Chronic Airway Inflammation: In Silico Mapping Of RNA-Binding Protein Expression 102
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 102
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 101
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 100
Transcription factors in asthma and COPD 100
Interaction between the promoter MUC5B polymorphism and mucin expression: is there a difference according to ILD subtype? 99
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 98
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 98
COPD exacerbations: definitions and classifications 98
Birbeck granules: contribution to the comprehension of intracytoplasmic evolution. 96
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 95
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 95
Controllo della broncopneumopatia cronica ostruttiva in Italia 95
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 94
The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide 94
Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study 94
Asthma death. 93
Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease 92
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 91
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 90
Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study 90
Chronic obstructive pulmonary disease and lung cancer: new molecular insights 90
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 89
Malattie virali dell’apparato respiratorio 89
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 89
Kinase targets and inhibitors for the treatment of airway inflammatory diseases: the next Generation of drugs for severe asthma and COPD?. 89
Asma. 88
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 88
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 88
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. 87
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians 87
La teofillina nella BPCO: nuove prospettive (3° parte). 86
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 86
Asma. 86
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 86
Molecular pathogenesis of cigarette smoking-induced stable COPD 86
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy. 85
High-Resolution Computed Tomography Quantitation of Emphysema Is Correlated with Selected Lung Function Values in Stable COPD. 85
Asthma: a chronic infectious disease? 85
RNA-Binding Proteins as a Molecular Link between COPD and Lung Cancer 84
Totale 12.247
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.135
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021129 0 0 0 0 0 0 0 0 0 59 44 26
2021/20221.666 5 65 5 273 27 13 181 87 19 72 335 584
2022/20232.892 366 187 104 152 133 182 35 96 1.549 8 52 28
2023/2024867 52 81 54 86 70 169 24 30 5 27 11 258
2024/20256.085 74 28 80 313 210 55 91 1.419 1.596 357 706 1.156
2025/202614.291 544 1.069 1.450 1.817 968 3.103 1.764 1.527 1.551 498 0 0
Totale 28.684